NCT05899777

Brief Summary

With mild cognitive impairment (MCI) as the research object, the intervention effect of Yizhi Baduanjin on mild cognitive impairment was evaluated by using the Montreal Cognitive Assessment (MoCA) scale, human-computer interactive electronic cognitive function score, multi-measure EEG data and other evaluation indicators, with the intervention measures of Yizhi Baduanjin created by the Tai Chi Health Center in the early stage. This project is based on the preliminary study, followed the principles and methods of clinical epidemiology and evidence-based medicine, and designed a prospective, randomized, single-blind, parallel controlled trial to make up for the deficiency of existing drugs in the intervention of mild cognitive impairment, and to provide evidence for the clinical and community promotion and application of effective and safe traditional Chinese medicine non-pharmaceuticals in the prevention and treatment of mild cognitive impairment.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2023

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 17, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

June 1, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 12, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

June 12, 2023

Status Verified

February 1, 2023

Enrollment Period

4 months

First QC Date

April 17, 2023

Last Update Submit

June 1, 2023

Conditions

Keywords

Mild Cognitive ImpairmentBaduanjin

Outcome Measures

Primary Outcomes (3)

  • MoCA

    The MoCA (Montreal Cognitive Assessment) is a tool used to assess cognitive function, primarily for the early detection of mild cognitive impairment and dementia. The MoCA scale consists of 30 questions, including evaluations of memory, attention, language, abstraction, orientation, spatial ability, and executive function. The scale includes more specific testing items, such as clock-drawing, reaction time, and number string recall. Each question has a standard answer or scoring criteria, and scores are totaled to a maximum of 30 points.The cutoffs for MCI are \<26.

    Change from Baseline MOCA at 4 weeks

  • MoCA

    The MoCA (Montreal Cognitive Assessment) is a tool used to assess cognitive function, primarily for the early detection of mild cognitive impairment and dementia. The MoCA scale consists of 30 questions, including evaluations of memory, attention, language, abstraction, orientation, spatial ability, and executive function. The scale includes more specific testing items, such as clock-drawing, reaction time, and number string recall. Each question has a standard answer or scoring criteria, and scores are totaled to a maximum of 30 points.The cutoffs for MCI are \<26.

    Change from 4 weeks MOCA at 12 weeks

  • MoCA

    The MoCA (Montreal Cognitive Assessment) is a tool used to assess cognitive function, primarily for the early detection of mild cognitive impairment and dementia. The MoCA scale consists of 30 questions, including evaluations of memory, attention, language, abstraction, orientation, spatial ability, and executive function. The scale includes more specific testing items, such as clock-drawing, reaction time, and number string recall. Each question has a standard answer or scoring criteria, and scores are totaled to a maximum of 30 points.The cutoffs for MCI are \<26.

    Change from 12 weeks MOCA at 24 weeks

Secondary Outcomes (6)

  • Cognitive Function Score

    Change from Baseline cognitive function score at 4 weeks

  • Cognitive Function Score

    Change from 4 weeks cognitive function score at 12 weeks

  • Cognitive Function Score

    Change from 12 weeks cognitive function score at 24 weeks

  • EEG data

    Change from Baseline EEG data at 4 weeks

  • EEG data

    Change from 4 weeks EEG data at 12 weeks

  • +1 more secondary outcomes

Study Arms (2)

Treatment group

EXPERIMENTAL

After proficiently mastering the complete set of Yizhi Baduanjin, the practice group is required to practice sitting posture of YizhiBaduanjin twice a day and standing posture of YizhiBaduanjin once every two days.

Other: Yizhi Baduanjin

control group

NO INTERVENTION

The control group is a waiting control group, and after 24 weeks, they will continue to learn the Yizhi Baduanjin.

Interventions

Yizhi Baduanjin is a newly compiled routine developed on the foundation of the traditional Baduanjin, aiming at the mental and cerebral health of middle-aged and elderly population, which combining the preliminary research result and principles of the traditional routine. It could be practiced in long term to prevent MCI and AD, or simply as a general health exercise for elders.

Treatment group

Eligibility Criteria

Age60 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjective symptoms include memory loss
  • MoCA score is less than 26 points
  • No disability, no communication barrier, and can complete the cognitive function test of human-computer interaction
  • Agree to participate in the project and sign the informed consent form

You may not qualify if:

  • Alzheimer's patients
  • Cognitive impairment caused by depression, cerebrovascular accident and other specific reasons
  • Those who are unwilling or unable to take part in the Yizhi Baduanjin exercise

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Cognitive Dysfunction

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 17, 2023

First Posted

June 12, 2023

Study Start

June 1, 2023

Primary Completion

October 1, 2023

Study Completion

December 1, 2023

Last Updated

June 12, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share